China Anti-Cancer Association (CACA) guidelines for holistic integrative management of cancer-peritoneal tumours from gastrointestinal tract.
10.3760/cma.j.cn441530-20221221-00533
- VernacularTitle:中国肿瘤整合诊治指南：腹膜肿瘤（胃肠肿瘤部分）
- Collective Name:Chinese Society of Peritoneal Oncology, China Anti-Cancer Association
- Publication Type:Journal Article
- MeSH:
Humans;
Peritoneal Neoplasms/secondary*;
Combined Modality Therapy;
Antineoplastic Combined Chemotherapy Protocols/therapeutic use*;
Quality of Life;
Prognosis;
Hyperthermia, Induced/methods*;
Gastrointestinal Tract;
Colorectal Neoplasms/pathology*;
Cytoreduction Surgical Procedures/methods*;
Survival Rate
- From:
Chinese Journal of Gastrointestinal Surgery
2023;26(2):111-120
- CountryChina
- Language:Chinese
-
Abstract:
Peritoneal tumours have a large population and a poor prognosis with limited therapeutic options available, and are common originated from gastric, colorectal, appendix and other cancers. Traditionally, peritoneal tumours have long been considered to be a terminal condition with a median survival of 3-6 months, and the palliative symptomatic treatment is recommended. Recently, the multimodal therapeutic strategy of cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has resulted in more effective on the prevention and treatment of peritoneal metastasis, which can significantly improve the survival and quality of life. Under the guidance of the China Anti-Cancer Association (CACA), the "CACA Guidelines for Holistic Integrative Management of Cancer-Peritoneal Tumours" was jointly completed by experts in related fields organized by the Chinese Society of Peritoneal Oncology. This guideline is guided by the concept of integrative medicine and focuses on the domestic epidemiology, genetic background and original studies. It emphasizes the multidisciplinary team to holistic integrative medicine (MDT to HIM), and pays attention to the whole-course management of "prevention, screening, diagnosis, treatment, and rehabilitation". This guideline mainly focuses on peritoneal metastasis from gastrointestinal tumours, aiming to standardize the clinical diagnosis and treatment process, and jointly promote the management of peritoneal metastasis in China.
